This invention relates to a method for synthesizing the
sitafloxacin intermediate 5-benzyl-7(S)-tert-butoxycarbonylamino-5-azaspiro[2,4]
heptane. The method uses 1-benzylmethylpyrrolidine-2,4-dione as the starting material and proceeds through five steps: cyclization,
oxime formation, chiral asymmetric reduction,
salt formation, and amino protection to obtain the target product. Specifically, the cyclization reaction uses an alkylating agent and a base to construct a spirocyclic structure; the
oxime reaction introduces a methoxyimino group via
methoxyamine hydrochloride; the chiral asymmetric reduction uses a catalytic
system composed of a
chiral ligand and a
boron reagent to construct the chiral center, followed by purification via
maleic acid salt formation; and finally, the amino group is protected with di-tert-butyl
dicarbonate to obtain the target product. This invention offers high
atom economy, good process
scalability, simple operation, controllable cost, and high product purity, providing a reliable intermediate synthesis scheme for the efficient preparation of
sitafloxacin active pharmaceutical ingredient.